Skip to content
10-K

Annual Report

Decibel Therapeutics, Inc.

0000950170-23-007849

← back to feed
Filed
Mar 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 1, 2023 25.01M sh
Shares Diluted FY 2022 · Dec 31, 2022 24.96M sh
Shares Diluted FY 2022 · Dec 31, 2021 21.73M sh
Capex FY 2022 · Dec 31, 2022 $463K
Capex FY 2022 · Dec 31, 2021 $745K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$56.9M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$43.15M
Cash And Equivalents FY 2022 · Dec 31, 2022 $34.61M
Cash And Equivalents FY 2022 · Dec 31, 2021 $36.46M
Stockholders Equity FY 2022 · Dec 31, 2022 $81.79M
Stockholders Equity FY 2022 · Dec 31, 2021 $141.69M
Stockholders Equity FY 2022 · Dec 31, 2020 −$54.78M
Current Liabilities FY 2022 · Dec 31, 2022 $22.44M
Current Liabilities FY 2022 · Dec 31, 2021 $20.54M
Total Liabilities FY 2022 · Dec 31, 2022 $41.58M
Total Liabilities FY 2022 · Dec 31, 2021 $42.79M
Current Assets FY 2022 · Dec 31, 2022 $108.03M
Current Assets FY 2022 · Dec 31, 2021 $164.19M
Total Assets FY 2022 · Dec 31, 2022 $123.37M
Total Assets FY 2022 · Dec 31, 2021 $184.48M
Eps Diluted FY 2022 · Dec 31, 2022 −$2.52
Eps Diluted FY 2022 · Dec 31, 2021 −$2.49
Eps Basic FY 2022 · Dec 31, 2022 −$2.52
Eps Basic FY 2022 · Dec 31, 2021 −$2.49
Sga Expense FY 2022 · Dec 31, 2022 $23.63M
Sga Expense FY 2022 · Dec 31, 2021 $20.38M
Rd Expense FY 2022 · Dec 31, 2022 $40.33M
Rd Expense FY 2022 · Dec 31, 2021 $29.85M
Net Income FY 2022 · Dec 31, 2022 −$63.01M
Net Income FY 2022 · Dec 31, 2021 −$51.82M
Operating Income FY 2022 · Dec 31, 2022 −$63.96M
Operating Income FY 2022 · Dec 31, 2021 −$50.23M